drugset
drugset / Trial / NCT01895205

Treatment of Women After Severe Postpartum Haemorrhage

NCT01895205 ↗

Phase 3 Completed 13 enrolled Pharmacosmos A/S BioStata · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The primary purpose of this study is to get explorative information about IV high single dose infusion of iron isomaltoside 1000 compared to RBC transfusion in the treatment of severe PP-IDA evaluated as physical fatigue

Timeline

Start
2013-06
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Iron isomaltoside 1000 Unknown 1500 mg Intravenous

Indications

No indication recorded.